ty800
Vaccineexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Feb 1, 2006 (NCT00269295)
Timeline
Indications
Mechanism of action
- Salmonella typhiImmunity, active
Salmonella typhi immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ty800
- ty800
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00498654 | Phase 2 | Jul 1, 2007 | Accelovance, Avant Immunotherapeutics |
| NCT00269295 | Phase 1/Phase 2 (Phase 2) | Feb 1, 2006 | National Institute of Allergy and Infectious Diseases (NIAID) |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Accelovance | For profit | 1 | 0 | 1 | 2007 |
| Avant Immunotherapeutics | For profit | 1 | 1 | 1 | 2007 |
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 1 | 1 | 1 | 2006 |
3 organizations
Page 1 / 1